Atlas Trials

Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)

Clinical trial NCT02375685 · TERMINATED

Trial details

NCT number
NCT02375685
Sponsor
Institut de Recherches Internationales Servier
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Uveitis
Start date
2014-08-01
Primary completion
2015-11-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.